We were delighted to be part of an event to explore the future of diabetes care, using design thinking.
Hosted by the Innovative Medicine Initiative (IMI), a group of the world’s leading experts on diabetes and metabolic disorders came together on the Island of Mainau in early 2017 with a very important purpose: to explore the 10-15 year future of the field, and identify the key challenges and opportunities that might arise.
Participants came from pharmaceutical companies, medical device manufacturers, patient advocacy groups, hospitals, high-tech and big data firms, and other related specialisms.
Supported by Treehouse Innovation and ExperiencePoint, individuals from across these domains worked together to envision possible futures and prioritize areas where greater collaboration could enable better outcomes for patients and their families in the future.
Output included consensus around key challenges, top priorities and an agreed plan of action.
Find out how a US-based college used the Innovation Impact Assessment as a part of its design thinking course.Read more
We were delighted to work with global consulting firm Accenture to help one of its innovation teams – The Accenture Canada Innovation Hub – become better innovators. By going through the Innovation Impact Assessment, followed […]Read more
AstraZeneca created ‘Our future reimagined’, its global transformation programme, to help it overcome the multitude of challenges facing the pharmaceutical industry – from increased use of digital technology, to changes affecting the supply chain. It […]Read more
If you can spare the time for a 30 min ZOOM call, a member of our senior team would be happy to discuss your aspirations and challenges, and explain how we can help.